TargEDys

3 articles about TargEDys

• French Biotech TargEDys® Announces Positive Results of Its Clinical Trial With Its Probiotic Strain Hafnia alvei HA4597™ on the Weight Loss Thanks to Regulation of Appetite

  2/6/2020

  TargEDys® announces the successful completion of its 3 months, randomized, double blind, placebo-controlled, multicentric clinical study carried out on 229 subjects and evaluating the efficacy of Hafnia alvei HA4597™ in the weight loss by regulation of the appetite.

• TargEDys Extends Series A And Appoints New Board Members

  4/11/2017

• TargEDys Develops New Microbiome-Based Solutions For Appetite Regulation And Announces A €5.8M International Round Of Financing To Demonstrate Product Clinical Efficacy

  4/14/2016